Abstract
Innate immune checkpoint CD47 has emerged as a prominent target for cancer immunotherapy and defining biomarkers predictive of response will be a crucial step towards clinical implementation. Hereto, we investigated the importance of a previously reported requisite for SLAM family member 7(SLAMF7) expression on cancer cell phagocytosis for effective CD47 antibody therapy.
| Original language | English |
|---|---|
| Article number | 1600349 |
| Number of pages | 3 |
| Journal | Molecular and Cellular Oncology |
| Volume | 6 |
| Issue number | 3 |
| DOIs |
|
| Publication status | Published - 1-Jan-2019 |
Keywords
- CD47
- DLBCL
- phagocytosis
- SLAMF7